Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan-Mar;13(1):55-61.
doi: 10.4103/jovr.jovr_190_17.

Evolution of Cyclophotocoagulation

Jideofor K Ndulue  1 , Kamran Rahmatnejad  1 , Carina Sanvicente  1 , Sheryl S Wizov  1 , Marlene R Moster  1
Affiliations
Review

Evolution of Cyclophotocoagulation

Jideofor K Ndulue et al. J Ophthalmic Vis Res. 2018 Jan-Mar.

Abstract

Cyclodestructive techniques have been a treatment option for refractory glaucoma since its first use in the 1930s. Over the past nine decades, cyclodestruction has advanced from the initial cyclodiathermy to micropulse transscleral cyclophotocoagulation (MP-TSCPC) which is the current treatment available. Complications associated with cyclodestruction including pain, hyphema, vision loss, hypotony and phthisis have led ophthalmologists to shy away from these techniques when other glaucoma treatment options are available. Recent studies have shown encouraging clinical results with fewer complications following cyclophotocoagulation, contributing greatly to the current increase in the use of cyclophotocoagulation as primary treatment for glaucoma. We performed our literature search on Google Scholar Database, Pubmed, Web of Sciences and Cochrane Library databases published prior to September 2017 using keywords relevant to cyclodestruction, cyclophotocoagulation and treatment of refractory glaucoma.

Keywords: Endocyclophotocoagulation; Glaucoma; Transcleral Cyclophotocoagulation; Transpupillary Cyclophotocoagulation.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Olmos LC, Lee RK. Medical and surgical treatment of neovascular glaucoma. Int Ophthalmol Clin. 2011;51:27–36. - PMC - PubMed
    1. Lee DA, Higginbotham EJ. Glaucoma and its treatment: A review. Am J Health Syst Pharm. 2005;62:691–699. - PubMed
    1. Shields MB, Shields SE. Noncontact transscleral Nd: YAG cyclophotocoagulation: A long-term follow-up of 500 patients. Trans Am Ophthalmol Soc. 1994;92:271–287. - PMC - PubMed
    1. Weve H. Die zyklodiatermie das corpus ciliare bei glaukom. Zentralbl Ophthalmol. 1933;29:562–569.
    1. Vogt A. Versuche zur intraokularen druckherabsetzung mittelst diatermiesehadigung des corpus ciliare (zyklodiatermiestichelung) Klin Monatsbl Augenheilkd. 1936;97:672–673.